Skip to main content

$0.065 0.001 (1.56%)

High

$0.07

Low

$0.07

Trades

2

Turnover

$1,268

Volume

19,512
30 June 2023 at 10:39am
Register to track HMD and receive email alerts.

HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. It also provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a cloud-based remote maternity care platform. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is based in Netanya, Israel.

Expand Company Description

Market Cap (10-Oct)

$13,931,500 (1,281st)

Close (30-Jun)

$0.065

Volume (30-Jun)

19,512

Shortsold (30-Oct)

11,888 (0.00%) (596th)

52w High

$0.064

52w Low

$0.012

P/E

-

EPS

-0.02
Subject
HMD Ann: E-Lovu signs first 3 year commercial agreement

HMD Ann: Further information - Strategic Partnership Rewards Platform

HMD Ann: Trading Halt

HMD Ann: Strategic Partnership signed - US employee rewards platform

HMD Ann: Results of Annual General Meeting

HMD Ann: Contract signed with private Obstetrics & Gynaecology Group

HMD Ann: Notice of Annual General Meeting/Proxy Form

HMD Ann: Quarterly Activities & Cashflow Report

HMD Ann: Final Director's Interest Notice

HMD Ann: Board & Management changes

HMD Ann: Date of AGM and Closing Date for Director Nominations

HMD Ann: Change of Director's Interest Notice

HMD Ann: Appendix 4G and Corporate Governance Statement

HMD Ann: Annual Report to shareholders

HMD Ann: Gold Coast Hospital to begin trial of the HeraCARE Platform

HMD Ann: Appendix 2A

HMD Ann: Cleansing Prospectus

HMD Ann: Proposed issue of securities - HMD

HMD Ann: Appendix 4E & Preliminary Final Report

HMD Ann: Successful First Phase - e-Lovu Initial Commercial Rollout

HMD Ann: Distribution Schedule

HMD Ann: Top 20 securityholders

HMD Ann: Results of Meeting

HMD Ann: Quarterly Activities & Cashflow Report

HMD Ann: Notification regarding unquoted securities - HMD

HMD Ann: Appointment of Keith Koby as President, North America

HMD Ann: HMD - Securities Trading Policy

HMD Ann: Correction - Notice of General Meeting

HMD Ann: Notice of General Meeting

HMD Ann: Ramsay Affiliated Melbourne Mothers Practice Adopts HeraCARE

HMD Ann: JHCs Clinical Trial Published in Nature Portfolio

HMD Ann: Quarterly Activities & Cashflow Report

HMD Ann: Notification regarding unquoted securities - HMD

HMD Ann: Notification regarding unquoted securities - HMD

HMD Ann: Notification regarding unquoted securities - HMD

HMD Ann: Cleansing Notice

HMD Ann: Application for quotation of securities - HMD

HMD Ann: Results of Annual General Meeting

HMD Ann: Initial Director's Interest Notice - Emily Slade

HMD Ann: Appointment of Emily Slade as a Non-Executive Director

HMD Ann: Notice of Annual General Meeting/Proxy Form

HMD Ann: Cleansing Notice

HMD Ann: Application for quotation of securities - HMD

HMD Ann: Appendix 4D and Half Year Report

HMD Ann: Proposed issue of securities - HMD

HMD Ann: HeraMED Completes $4 Million Private Placement

HMD Ann: Trading Halt

HMD Ann: Notification of cessation of securities - HMD

HMD Ann: Notification of cessation of securities - HMD

HMD Ann: Notification regarding unquoted securities - HMD

Register to track HMD and receive email alerts.